Abbott’s Revised Meridia Labeling Adds Renal Precaution
This article was originally published in The Pink Sheet Daily
Executive Summary
Revised labeling for Abbott's Meridia (sibutramine) includes a precaution against using the weight-loss drug in patients with mild to moderate renal impairment or renal insufficiency